<scp>PAK1</scp> mediates pancreatic cancer cell migration and resistance to <scp>MET</scp> inhibition
Wei Zhou(Broad Institute), Klaus P. Hoeflich(Pivot), Richard M. Neve(Lawrence Berkeley National Laboratory), Christian Pilarsky(University Hospital Carl Gustav Carus), Florian Gnad(Cell Signaling Technology (United States)), Adrian M. Jubb(Allogene Therapeutics (United States)), Ana De Jesus‐Acosta(Johns Hopkins University), William F. Forrest, Daniela Aust(University Hospital Carl Gustav Carus), Marcia Belvin(CytomX Therapeutics (United States)), Hartmut Koeppen, Qian Xiao(Zhejiang Cancer Hospital), Rajiv Raja(AstraZeneca (United States)), Elizabeth M. Jaffee(Bloomberg (United States)), Peter M. Haverty, Mally Romero(Translational Research in Oncology), Mark Merchant(Revolution Medicines (United States)), Yulei Wang, Lei Zheng(Fujian Medical University), Ling Fu(Kunming Medical University), Lori S. Friedman, Christy C. Ong(Gene Therapy Laboratory), Rupal Desai(Genentech), Yibing Yan(Anhui Medical University), Karen S. Lyle(Sunesis (United States)), Robert Grützmann(University Hospital Carl Gustav Carus), Qinghua Song(Biostatistical Consulting (United States)), Klára Tótpál
Cited by 56